Document Detail


Antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 male mice with myocardial infarction and systemic lupus erythematosus.
MedLine Citation:
PMID:  7723359     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We examined the antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 [(WxB)F1] male mice with myocardial infarction (MI) and systemic lupus erythematosus (SLE). Ticlopidine (3 and 10 mg/kg) was given to the mice as an additive to a standard laboratory diet from the time the mice were aged 16-24 weeks. The higher dose of ticlopidine significantly increased survival rate of the mice. In mice that received 10 mg/kg ticlopidine, the incidence of MI, the percentage of MI area (%MI), and the incidence and number of small coronary arteries with significant stenosis were significantly lower than in controls. The stenosed lesions were divided into occlusive thrombi related to acute MI and intimal thickening related to old MI. No mice had evidence of significant stenosis or thrombosis in the extramyocardial coronary arteries. Glomerulonephritis, blood urea nitrogen (BUN), and circulating immune complexes were not significantly different among the three groups. A high dose of ticlopidine prevented small coronary artery disease and MI and increased the survival of (WxB)F1 male mice, suggesting that this agent has an antithrombotic effect on occlusive thrombi of the small coronary arteries in such mice.
Authors:
H Suzuka; H Fujiwara; M Tanaka; H Yoshifusa; Y Nakamura; Y Shibata
Related Documents :
15672279 - Evaluation of penile perfusion by color-coded duplex sonography in the management of er...
7502959 - Ct-defined large subcortical infarcts: correlation of location with site of cerebrovasc...
14583309 - Acute effects of tourniquet occlusion and intraluminal shunts in beating heart surgery.
2941669 - Waveform analysis applied to laser doppler flowmetry.
1675639 - Intracarotid infusion of leukotriene c4 selectively increases blood-brain barrier perme...
15891159 - Vascular occlusion sites determine differences in lesion growth from early apparent dif...
7059409 - Rapid disappearance of left ventricular mass (presumed thrombus) in a patient with card...
9882789 - Strategies to prevent neurologic deficit based on motor-evoked potentials in type i and...
18580239 - Cardiac fusion imaging with low-dose computed tomography using prospective electrocardi...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  25     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1995 Jan 
Date Detail:
Created Date:  1995-05-22     Completed Date:  1995-05-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  9-13     Citation Subset:  IM    
Affiliation:
Yamashina Laboratories, Nippon Shinyaku Co., Ltd, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Animals
Antigen-Antibody Complex / blood
Blood Urea Nitrogen
Coronary Disease / pathology
Coronary Thrombosis / drug therapy,  prevention & control*
Disease Models, Animal
Glomerulonephritis / pathology
Lupus Erythematosus, Systemic / drug therapy*,  metabolism,  mortality
Male
Mice
Myocardial Infarction / drug therapy*,  metabolism,  mortality
Myocardium / cytology,  pathology
Random Allocation
Survival Rate
Ticlopidine / administration & dosage,  pharmacology*,  therapeutic use
Chemical
Reg. No./Substance:
0/Antigen-Antibody Complex; 55142-85-3/Ticlopidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis...
Next Document:  Racial differences in beta-adrenoceptor-mediated responsiveness.